Last reviewed · How we verify
NCT04377607
Haemoglobin Concentration on COVID-19
trial testing File scanning in Corona Virus Infection in 200 participants. Status unknown.
20 November 2020
Quick facts
| Lead sponsor | Nevsehir Public Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 November 2020 |
| Primary completion | 20 November 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- File scanning
Conditions studied
- Corona Virus Infection — all drugs for Corona Virus Infection →
Sponsor
Nevsehir Public Hospital
Who can join
Eligibility, any sex, with Corona Virus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A rapid oxygen desaturation has observed in patients with COVID-19 which have seriously respiratory failure and most of them have intubated and connected to the mechanical ventilator. Finally, many of them have died during the process. ORF8 and superficial glycoproteins of a novel coronavirus bind to porphyrin on haemoglobin molecules and inhibit heme metabolism in an erythrocyte. However, it is not clarify the effects of the novel coronavirus on mean corpuscular volume (MCV), mean corpuscular of haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04377607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Corona Virus Infection
Currently open trials in the same condition.
- NCT05765396 — SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies · active not recruiting
- NCT05684549 — Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung Cancer · active not recruiting
- NCT04382846 — Novel Regimens in COVID-19 Treatment · Phase 3 · recruiting
- NCT04371315 — Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children · recruiting
- NCT04359836 — A Study to Explore the Role of Gut Flora in COVID-19 Infection · recruiting
Other Nevsehir Public Hospital trials
Trials by the same sponsor.
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06915376 — "AI-Based Noninvasive Blood Pressure Monitoring Compared to Invasive Arterial Measurement" · completed
- NCT06752421 — Effect of Low Tidal Volume Ventilation on Postoperative Delirium · NA · completed
- NCT06213389 — Comparison of EzVision® Videolaryngoscope and Gum Elastic Bougie-Assisted Machintosh Laryngoscopy · NA · completed
- NCT05552794 — Prognostic Value With Combined ONSD and NIRS Measurements for Predicting Neurological Outcome After Cardiac Arrest · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04377607 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nevsehir Public Hospital
- Last refreshed: 16 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04377607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing